Please login to the form below

Proteomics

This page shows the latest Proteomics news and features for those working in and with pharma, biotech and healthcare.

Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies

The drug discovery company will use its platform, which combines high-throughput chemoproteomics-based screening in the native setting with structural proteomics.

Latest news

Sanofi reports positive new data for multiple sclerosis treatment tolebrutinib

The study, which saw the company collaborate with the National Institute of Neurological Disorders and Stroke, involved researchers measuring proteomic changes in the cerebrospinal fluid of MS patients treated with tolebrutinib,
Researchers create ‘world’s largest’ database for predicting cancer treatment response

In the study, CMRI’s ProCan team used mass spectrometry to measure thousands of different proteins in very large numbers of cancers and, using this methodology, generated a proteomic database for ... Commenting on the study’s results, Roger Reddel, a
ICR scientists create AI test to predict cancer drug combinations

As part of the study, scientists carried out ‘proteomic’ analyses and observed changes in 52 key proteins and their interaction with each other in response to drug treatments.
Research charity LifeArc cashes $1.2bn royalty from Keytruda

launched a biomarker and proteomics alliance with the Medicines Discovery Catapult.
Medicines Discovery Catapult to collaborate with LifeArc on new biomarkers

Will also advance proteomics research. The UK’s Medicines Discovery Catapult has teamed up with LifeArc in a bid to develop novel biomarkers and optimise the medical charity's drug development. ... This new post-doc will centre around proteomics, the

More from news
Approximately 1 fully matching, plus 21 partially matching documents found.

Latest Intelligence

The increasing value of rare disease trials

Advances in genomics, proteomics and other areas of scientific research have led to a better understanding of the underlying mechanisms of many rare diseases, providing new targets for drug development.
Communication is the key to unlocking the potential of immuno-oncology

The science of ‘omics’ – genomics, proteomics, metabolomics – has already taught us that the Big C is far from a singular entity, but is more like thousands of individual diseases caused by
Medical affairs

analysis of ‘big data’, genomic and proteomic diagnosis and personalised medicine.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Horizon Discovery appoints executive director

He also served as president of ProteoPlex, a seed stage spinout focusing on proteomics, which was acquired by Merck KGaA in 2003, and founded Genomes Systems, acquired by Incyte Genomics in

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Personalized Oncology: Calling for a New Kind of Partnership:

We need mathematicians and engineers, too. Frankly, biomarker research tends attract biologists interested in areas such as genomics and proteomics rather than engineers.
From Academics to Entrepreneurship: How Tech is Revolutionizing the Diagnostics Landscape

Joshua Yang, Co-founder &CEO of Glyphic Biotechnologies and Co-founder of NephroSant, dives into next-generation protein sequencing for biomedical research and clinical medicine, his journey from academia to entrepreneurship, and much more.
COUCH Health celebrates a trio of new hires including a Global Director

With a background in Advanced Genomic and Proteomic Sciences, he decided to channel his knowledge into supporting clinical research clients solve their complex problems.
JPT Peptide Technologies

JPT Peptide Technologies GmbH is a leading provider of innovative peptide-based services, and catalog products &kits, as well as a research and development partner for projects in Immunotherapy, Immunology, Proteomics
Creative Proteomics

Creative Proteomics provides a comprehensive range of proteomics services using both gel-based and gel-free proteome analysis platforms. ... We offer quality proteomics services for target identification, lead optimization and preclinical and clinical

More from PMHub
Approximately 1 fully matching, plus 4 partially matching documents found.

Subscribe to our email news alerts

Account Manager, 6 month contract, Healthcare Brand communicatio...: Highly competitive salary

Senior Medical Copywriter - Highly Awarded Advertising Agency: £50,000 - £60,000 yearly

Account Manager, Healthcare Marketing Creative Agency, Fixed ter...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Home Based Account Manager, Medical Communications, UK, Pharma/M...: Highly competitive salary

Account Director, Healthcare Marketing Creative Agency, Fixed te...: Highly competitive salary

No results were found

PMHub

Add my company

Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Parkinson’s disease: past, present and future: Examining the history and complexities of Parkinson’s disease – one of the most prevalent neurodegenerative disorders that affects over 10 million people worldwide...
The 17th World Congress on Controversies in Neurology: This year, there was a focus on the rare disease neuromyelitis optica spectrum disorder that strikes suddenly and mainly impacts women...
Archetypes: Rethinking go-to-market expectations to drive commercial success: In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...

Email:
Password:

Please login to the form below

Proteomics

Subscribe to our email news alerts

Quick links